H Yamamoto, H Okamoto. Show Affiliations »
Abstract
Entities: Chemical Disease Gene
Mesh: See more » Amides/pharmacologyAnimalsCell Nucleus/drug effectsDiabetes Mellitus, Experimental/chemically inducedIslets of Langerhans/drug effectsIslets of Langerhans/metabolismMaleNAD/metabolismNAD+ Nucleosidase/antagonists & inhibitorsNiacinamide/pharmacologyPicolinic Acids/pharmacologyPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases/metabolismProinsulin/biosynthesisRatsStreptozocin/antagonists & inhibitors
Substances: See more » AmidesPicolinic AcidsPoly(ADP-ribose) Polymerase InhibitorsNADNiacinamideStreptozocinProinsulinPoly(ADP-ribose) PolymerasesNAD+ Nucleosidasepicolinamide
Year: 1980 PMID: 6251809 DOI: 10.1016/0006-291x(80)90762-7
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575